Publicly Traded Biotech and Pharmaceutical Companies in Massachusetts
The companies on this list are biotech and pharmaceutical companies headquartered in Massachusetts. Examples of some of the larger companies on this list based on market capitalization include:
Alnylam Pharmaceuticals, Inc. (ALNY)
Vertex Pharmaceuticals Incorporated (VRTX)
Select the company’s link to access charts, news links and company website and social media information.
Biotech and Pharmaceutical Companies
Acceleron Pharma Inc. (XLRN) (Cancer and orphan diseases)
Agenus Inc. (AGEN) (Immunology: cancer, infectious diseases)
Agios Pharmaceuticals, Inc. (AGIO) (Biopharmaceutical company: cancer and rare genetic disorders of metabolism)
Aileron Therapeutics, Inc. (ALRN) (IPO June 29, 2017; biopharmaceutical company: cancer)
Akcea Therapeutics, Inc. (AKCA) (IPO July 14, 2017; biopharmaceutical company: cardiometabolic lipid disorders)
Akebia Therapeutics, Inc. (AKBA) (Biopharmaceutical company: anemia secondary to chronic kidney disease)
Aldeyra Therapeutics, Inc. (ALDX) (Treat diseases thought to be related to endogenous free aldehydes)
Allena Pharmaceuticals, Inc. (ALNA) (IPO November 2, 2017; biopharmaceutical company: metabolic and kidney disorders)
Alnylam Pharmaceuticals, Inc. (ALNY) (Biopharmaceutical company: RNAi therapeutics as genetic medicines; serious, life-threatening diseases)
AMAG Pharmaceuticals, Inc. (AMAG) (Chronic kidney disease, oral rinse for oral mucositis, umbilical cord blood stem cell collection and storage)
Anika Therapeutics Inc. (ANIK) (Therapeutic products for tissue protection, healing and repair; animal health, ophthalmic, joint health and orthopedic products, surgical products to treat ENT disorders, wound care products)
ArQule, Inc. (ARQL) (Small molecule cancer therapeutics)
Arsanis, Inc. (ASNS) (IPO November 16, 2017; biopharmaceutical company: infectious diseases)
AVEO Pharmaceuticals, Inc. (AVEO) (Biopharmaceutical company: therapies through biomarker-driven insights)
Biogen Inc. (BIIB) (Biopharmaceutical company: therapies for immunology, hematology, multiple sclerosis, neurology)
Bioverativ Inc. (BIVV) (Biotech company: hemophilia and other rare blood disorders)
Bluebird Bio, Inc. (BLUE) (Gene therapies for severe genetic and rare diseases)
Blueprint Medicines Corporation (BPMC) (IPO in April 2015: Biopharmaceutical company: kinase inhibitors for genomically defined cancers)
Catabasis Pharmaceuticals Inc. (CATB) (Biopharmaceutical company: rare diseases, serious lipid disorders)
Chiasma Inc. (CHMA) (IPO in July 2015, biopharmaceutical company: oral versions of injected drugs for orphan diseases)
Collegium Pharmaceutical, Inc. (COLL) (IPO in May 2015: Products designed to treat chronic pain while deterring drug abuse/misuse)
Concert Pharmaceuticals, Inc. (CNCE) (CNS disorders, renal disease, inflammation and cancer)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) (Biopharmaceutical company: rare, life-threatening, inflammatory diseases)